These components create an immunosuppressive milieu that suppresses effective anti-tumor immune responses, with MDSCs, in particular, inhibiting the activation and function of CD8+ T cells, thereby reinforcing resistance to ICIs [96]. This evidence concerns the gene CD8A and neoplasm.